Terese Hammond, MD, on Promising Data With iNKT Cells in COVID-associated ARDS
Terese Hammond, MD, on Investigating iNKT Cells in COVID-Associated ARDS
Lexington-based company reports promising results in trials for cancer-treating cell therapy
Massachusetts company MiNK Therapeutics working to make chemotherapy a thing of the past
Biotech’s ‘sugar high’ led to a correction, but winter doldrums could make way for a turnaround story this fall
Living Diversity, Inside Mink Therapeutics
Developing Invariant Natural Killer T Cells for Multiple Myeloma, GVHD
Ep#40: Eliminating Cancer Using Invariant Natural Killer T Cells (iNKTs) with Dr. Jennifer Buell
Your immunity is living medicine that can save lives, today. | Jennifer Buell | TEDxBoston
Advantages of Invariant Natural Killer T Cell Therapies